{
    "nctId": "NCT04914663",
    "briefTitle": "All-extremity Exercise During Breast Cancer Chemotherapy",
    "officialTitle": "All-extremity Exercise as a Novel Strategy for Optimizing Cardiovascular Function During Chemotherapy for Breast Cancer",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 68,
    "primaryOutcomeMeasure": "Change in brachial artery FMD",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Active diagnosis of primary invasive non-metastatic breast cancer, stages I-III\n* Female\n* 18 to 85 years of age\n* Scheduled to initiate neoadjuvant or adjuvant chemotherapy (anthracycline, alkylating agent and/or taxane)\n* Absence of contraindications to exercise\n* Study clinician approval\n* Able to give consent\n* Informed consent obtained from the subject and documentation of subject agreement to comply with study-related process\n\nExclusion Criteria:\n\n* Do not meet inclusion criteria\n* Receiving targeted therapies (CDK4/6 or PARP inhibitors)\n* Receiving radiation therapy concurrent with chemotherapy\n* Lymphedema stage \u2265 2 prior to study enrollment\n* Any relevant cardiovascular diseases (stroke, heart failure, myocardial ischemia during maximal graded exercise test, myocardial infarction, angina pectoris, coronary artery bypass surgery or angioplasty or coronary stent)\n* Current participation in other experimental interventions that may confound interpretation of study findings (e.g., dietary intervention for weight loss)",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}